|
US3051621A
(en)
*
|
1959-10-22 |
1962-08-28 |
Grove Lab Inc |
Gel composition, pressurized container with same, and method of preparation
|
|
US3050443A
(en)
*
|
1960-02-16 |
1962-08-21 |
James F Schuyler |
Headache remedy containing ammonia
|
|
US3039928A
(en)
*
|
1960-03-17 |
1962-06-19 |
Abbott Lab |
Stable aqueous isoproteronol compositions
|
|
NL262354A
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
*
|
1960-03-17 |
|
|
|
|
US3088874A
(en)
*
|
1960-05-23 |
1963-05-07 |
Union Carbide Corp |
Powder aerosol
|
|
US3282781A
(en)
*
|
1960-11-25 |
1966-11-01 |
Merck & Co Inc |
Inhalant compositions
|
|
BE632504A
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
*
|
1962-05-24 |
|
|
|
|
US3169095A
(en)
*
|
1962-10-30 |
1965-02-09 |
Rexall Drug Chemical |
Self-propelling powder-dispensing compositions
|
|
NL302251A
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
*
|
1963-01-28 |
1965-10-11 |
|
|
|
US3710782A
(en)
*
|
1969-10-01 |
1973-01-16 |
Hauser Res And Eng Co |
Method of treating human skin with a composition for electromedical applications
|
|
FI770215A7
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
*
|
1976-01-30 |
1977-07-31 |
Fisons Ltd |
|
|
AU522792B2
(en)
*
|
1977-07-19 |
1982-06-24 |
Fisons Plc |
Pressure pack formulation
|
|
US4352789A
(en)
*
|
1980-03-17 |
1982-10-05 |
Minnesota Mining And Manufacturing Company |
Aerosol compositions containing finely divided solid materials
|
|
US4655231A
(en)
*
|
1984-01-09 |
1987-04-07 |
Advanced Tobacco Products, Inc. |
Snuff and preparation thereof
|
|
US4576949A
(en)
*
|
1984-05-07 |
1986-03-18 |
The Upjohn Company |
Use of 5,6,7,8-tetrahydroquinolines and 5,6-dihydropyrindines as leukotriene and lipoxygenase inhibitors and the novel 3-substituted compounds therein
|
|
EP0213108A3
(de)
*
|
1985-06-26 |
1987-07-15 |
Kurt Dr. Burghart |
Pharmazeutische Zubereitung mit einem Antihypotonikum als wirksames Mittel
|
|
JPH0645538B2
(ja)
*
|
1987-09-30 |
1994-06-15 |
日本化薬株式会社 |
ニトログリセリンスプレー剤
|
|
FR2625677A1
(fr)
*
|
1988-01-07 |
1989-07-13 |
Cosnier Alain |
Composition medicamenteuse destinee a etre administree sous forme d'aerosol
|
|
DE68915203T2
(de)
*
|
1988-03-22 |
1994-09-22 |
Fisons Plc, Ipswich, Suffolk |
Pharmazeutische Mischungen.
|
|
US5776434A
(en)
*
|
1988-12-06 |
1998-07-07 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
|
US5225183A
(en)
*
|
1988-12-06 |
1993-07-06 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
|
US5439670A
(en)
*
|
1989-11-28 |
1995-08-08 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
|
DE4003270A1
(de)
*
|
1990-02-03 |
1991-08-08 |
Boehringer Ingelheim Kg |
Neue treibgase und ihre verwendung in arzneimittelzubereitungen
|
|
US5118494A
(en)
*
|
1990-03-23 |
1992-06-02 |
Minnesota Mining And Manufacturing Company |
Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
|
|
US5175152A
(en)
*
|
1990-09-28 |
1992-12-29 |
Singh Nikhilesh N |
Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
|
|
MX9203481A
(es)
|
1990-10-18 |
1992-07-01 |
Minnesota Mining & Mfg |
Formulaciones.
|
|
US5785952A
(en)
*
|
1990-11-09 |
1998-07-28 |
Glaxo Group Limited |
Aerosol medicament formulation having a surface coating of surfactant
|
|
US5919435A
(en)
|
1990-11-09 |
1999-07-06 |
Glaxo Group Limited |
Aerosol formulation containing a particulate medicament
|
|
ATE339952T1
(de)
|
1991-06-10 |
2006-10-15 |
Schering Corp |
Fluorchlorkohlenwasserstofffreie aerosolformulierungen
|
|
US5234933A
(en)
*
|
1991-10-31 |
1993-08-10 |
Board Of Governors Of Wayne State University And Vanderbilt University |
Cyclic hydroxamic acids
|
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
|
US5674471A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and salbutamol
|
|
US5744123A
(en)
*
|
1991-12-12 |
1998-04-28 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
|
IL104068A
(en)
*
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
|
|
US5653962A
(en)
*
|
1991-12-12 |
1997-08-05 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
|
US5916540A
(en)
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
|
DK0616525T3
(da)
*
|
1991-12-12 |
1996-01-08 |
Glaxo Group Ltd |
Medikamenter
|
|
EP0616524B1
(en)
*
|
1991-12-12 |
1998-10-07 |
Glaxo Group Limited |
Medicaments
|
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
|
DK1086688T3
(da)
*
|
1991-12-18 |
2004-08-16 |
Minnesota Mining & Mfg |
Aerosolformuleringer til suspensioner
|
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
|
US7105152B1
(en)
|
1991-12-18 |
2006-09-12 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
|
RU2126248C1
(ru)
*
|
1992-12-09 |
1999-02-20 |
Берингер Ингельхейм Фармасьютикалз, Инк. |
Жидкая фармацевтическая композиция в форме аэрозоля
|
|
ATE163006T1
(de)
*
|
1993-06-01 |
1998-02-15 |
Ono Pharmaceutical Co |
Pentansäurederivate
|
|
EP0640609A1
(en)
*
|
1993-08-24 |
1995-03-01 |
Ono Pharmaceutical Co., Ltd. |
Fused phenol derivatives having inhibitory activity on TXA2 synthetase, and 5-lipoxygenase and scavenging activity on oxygen species
|
|
EP0656349B1
(en)
*
|
1993-12-03 |
1998-04-08 |
Ono Pharmaceutical Co., Ltd. |
Amidinophenol derivatives having phospholipase A2 inhibitory activity
|
|
ES2145254T3
(es)
*
|
1993-12-20 |
2000-07-01 |
Minnesota Mining & Mfg |
Formulaciones de aerosoles que contienen flunisolida.
|
|
DK0703216T3
(da)
|
1994-09-20 |
1999-10-18 |
Ono Pharmaceutical Co |
Amidinophenolderivater som proteaseinhibitorer
|
|
US5840213A
(en)
*
|
1995-04-28 |
1998-11-24 |
Great Lakes Chemical Corporation |
Uses of heptafluoropropane
|
|
US5679287A
(en)
*
|
1995-04-28 |
1997-10-21 |
Great Lakes Chemical Corporation |
Uses of heptafluoropropane
|
|
KR980009238A
(ko)
|
1995-07-28 |
1998-04-30 |
우에노 도시오 |
설포닐아미노산 유도체
|
|
EP0757984B1
(en)
*
|
1995-08-08 |
2002-10-30 |
Ono Pharmaceutical Co., Ltd. |
Hydroxamic acid derivatives useful for inhibiting gelatinase
|
|
AUPN814496A0
(en)
*
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
|
US5861268A
(en)
*
|
1996-05-23 |
1999-01-19 |
Biomide Investment Limited Partnership |
Method for induction of tumor cell apoptosis with chemical inhibitors targeted to 12-lipoxygenase
|
|
US6054488A
(en)
*
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
|
GB9616237D0
(en)
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
|
NZ337065A
(en)
|
1997-02-05 |
2001-02-23 |
Jago Pharma Ag |
Medical aerosol formulations containing carbon dioxide, a hydrofluoroalkane, a cosolvent and a beta-mimetic / corticoid / anticholinergic / spasmolytic / analgesic agent
|
|
US6129905A
(en)
*
|
1997-04-21 |
2000-10-10 |
Aeropharm Technology, Inc. |
Aerosol formulations containing a sugar as a dispersant
|
|
US5891420A
(en)
*
|
1997-04-21 |
1999-04-06 |
Aeropharm Technology Limited |
Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
|
|
US5891419A
(en)
*
|
1997-04-21 |
1999-04-06 |
Aeropharm Technology Limited |
Environmentally safe flunisolide aerosol formulations for oral inhalation
|
|
US7153866B1
(en)
*
|
1997-05-27 |
2006-12-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of tempol for the treatment of Li-Fraumeni syndrome and ataxia telangiectasia
|
|
US20010031244A1
(en)
*
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
|
JPH11187882A
(ja)
|
1997-12-26 |
1999-07-13 |
Ono Pharmaceut Co Ltd |
新規なポリペプチド、その製造方法、そのポリペプチドをコードするｃＤＮＡ、そのｃＤＮＡからなるベクター、そのベクターで形質転換された宿主細胞、そのポリペプチドの抗体、およびそのペプチドまたは抗体を含有する薬学的組成物
|
|
DE59911149D1
(de)
|
1998-07-24 |
2004-12-30 |
Jago Res Ag Muttenz |
Medizinische aerosolformulierungen
|
|
DE59904648D1
(de)
|
1998-08-04 |
2003-04-24 |
Jago Res Ag Muttenz |
Medizinische aerosolformulierungen
|
|
US6458338B1
(en)
|
1998-09-22 |
2002-10-01 |
Aeropharm Technology Incorporated |
Amino acid stabilized medicinal aerosol formulations
|
|
US6136294C1
(en)
*
|
1998-09-22 |
2002-09-24 |
Aeropharm Technology Inc |
Amino acid stabilized medical aerosol formulation
|
|
DZ2947A1
(fr)
*
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
|
US6315985B1
(en)
*
|
1999-06-18 |
2001-11-13 |
3M Innovative Properties Company |
C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
|
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
|
JP4273407B2
(ja)
|
2001-07-23 |
2009-06-03 |
小野薬品工業株式会社 |
Ｅｐ４アゴニストを有効成分とする骨量低下疾患の治療剤
|
|
EP1477175B1
(en)
|
2002-02-19 |
2011-04-27 |
Ono Pharmaceutical Co., Ltd. |
Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
|
|
US7582284B2
(en)
*
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
|
KR20100055542A
(ko)
*
|
2002-06-25 |
2010-05-26 |
애크럭스 디디에스 피티와이 리미티드 |
비정질 약학적 조성물을 이용한 경피전달속도의 제어
|
|
US20050181032A1
(en)
*
|
2002-06-25 |
2005-08-18 |
Acrux Dds Pty Ltd. |
Metastable pharmaceutical compositions
|
|
US20050186141A1
(en)
*
|
2002-06-25 |
2005-08-25 |
Acrux Dds Pty Ltd. |
Transdermal aerosol compositions
|
|
AU2003248245A1
(en)
|
2002-06-26 |
2004-01-19 |
Ono Pharmaceutical Co., Ltd. |
Remedies for diseases caused by vascular contraction or dilation
|
|
EP3287144A1
(en)
|
2002-07-03 |
2018-02-28 |
ONO Pharmaceutical Co., Ltd. |
Immunopotentiating compositions
|
|
WO2004031118A1
(ja)
|
2002-10-03 |
2004-04-15 |
Ono Pharmaceutical Co., Ltd. |
Ｌｐａ受容体拮抗剤
|
|
DK2465537T3
(en)
|
2002-10-10 |
2016-09-19 |
Ono Pharmaceutical Co |
MICROSPHERE INCLUDING ONO-1301
|
|
WO2004032964A1
(ja)
*
|
2002-10-10 |
2004-04-22 |
Ono Pharmaceutical Co., Ltd. |
アレルギー性疾患治療剤
|
|
WO2004072286A1
(ja)
|
2003-01-23 |
2004-08-26 |
Ono Pharmaceutical Co., Ltd. |
ヒトｐｄ−１に対し特異性を有する物質
|
|
BRPI0408332A
(pt)
|
2003-03-14 |
2006-03-21 |
Ono Pharmaceutical Co |
derivados heterocìclicos contendo nitrogênio e medicamentos contendo os mesmos como ingrediente ativo
|
|
EP1619193A4
(en)
|
2003-04-18 |
2010-08-11 |
Ono Pharmaceutical Co |
SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF
|
|
AU2004240629B2
(en)
*
|
2003-05-16 |
2010-02-25 |
Arriva Pharmaceuticals, Inc. |
Treatment of respiratory disease by inhalation of synthetic matrix metalloprotease inhibitors
|
|
WO2006031210A1
(en)
|
2003-05-29 |
2006-03-23 |
Board Of Regents, The University Of Texas Systems |
Jabi as a prognostic marker and a therapeutic target for human cancer
|
|
US20070270489A1
(en)
|
2003-07-25 |
2007-11-22 |
Ono Pharmaceutical Co., Ltd. |
Remedy for Cartilage-Related Diseases
|
|
EP2883865B1
(en)
|
2003-08-29 |
2019-09-25 |
Ono Pharmaceutical Co., Ltd. |
Compound capable of binding S1P receptor and pharmaceutical use thereof
|
|
NZ545666A
(en)
|
2003-09-01 |
2009-11-27 |
Ono Pharmaceutical Co |
Condensed ring compound and use thereof
|
|
JP2007505136A
(ja)
*
|
2003-09-10 |
2007-03-08 |
マツプ・フアーマシユーテイカルズ・インコーポレーテツド |
ジヒドロエルゴタミンを肺吸入により体循環に送達するためのエアゾール製剤
|
|
KR20060106823A
(ko)
*
|
2003-10-20 |
2006-10-12 |
쉐링 코포레이션 |
약제학적 에어로졸 조성물
|
|
EP1698375B1
(en)
|
2003-12-25 |
2014-04-02 |
Ono Pharmaceutical Co., Ltd. |
Azetidine ring compounds and drugs comprising the same
|
|
US20060018840A1
(en)
*
|
2004-06-28 |
2006-01-26 |
Nektar Therapeutics |
Aerosolizable formulation comprising nicotine
|
|
JP5272310B2
(ja)
|
2004-10-21 |
2013-08-28 |
小野薬品工業株式会社 |
免疫抑制受容体の用途
|
|
ATE443516T1
(de)
*
|
2004-11-24 |
2009-10-15 |
Alcon Inc |
Verfahren zur verabreichung eines nasensprays
|
|
JP2008528694A
(ja)
|
2005-02-02 |
2008-07-31 |
ミトス・ファーマシューティカルズ・インコーポレーテッド |
糖尿病の治療または予防において使用するためのニトロキシド類
|
|
NZ597290A
(en)
|
2005-05-18 |
2013-07-26 |
Mpex Pharmaceuticals Inc |
Aerosolized fluoroquinolones and uses thereof
|
|
US8524735B2
(en)
*
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
|
EP2656860B1
(en)
*
|
2005-06-17 |
2021-05-05 |
Wisconsin Alumni Research Foundation |
Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
|
|
DK1942108T3
(da)
|
2005-10-28 |
2013-12-09 |
Ono Pharmaceutical Co |
Forbindelse indeholdende basisk gruppe samt anvendelse deraf
|
|
EP1961745A1
(en)
|
2005-12-12 |
2008-08-27 |
Ono Pharmaceutical Co., Ltd. |
Bicyclic heterocyclic compound
|
|
US20100184771A1
(en)
|
2005-12-15 |
2010-07-22 |
Ono Pharmaceutical Co., Ltd. |
Bicyclic Heterocyclic Compound
|
|
US20070286814A1
(en)
*
|
2006-06-12 |
2007-12-13 |
Medispray Laboratories Pvt. Ltd. |
Stable aerosol pharmaceutical formulations
|
|
CN101677954A
(zh)
*
|
2007-02-11 |
2010-03-24 |
Map药物公司 |
治疗性施用dhe用于快速减轻偏头痛而使副作用分布最小化的方法
|
|
TW200902019A
(en)
|
2007-04-26 |
2009-01-16 |
Ono Pharmaceutical Co |
Dicyclic heterocyclic compound
|
|
DE102008007198A1
(de)
|
2008-02-01 |
2009-08-13 |
Infectopharm Arzneimittel Und Consilium Gmbh |
Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften
|
|
NO2344129T3
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
*
|
2008-10-07 |
2018-07-21 |
|
|
|
DK2346509T3
(da)
*
|
2008-10-07 |
2020-08-03 |
Horizon Orphan Llc |
Inhalation af levofloxacin til at reducere lungeinflammation
|
|
TWI469965B
(zh)
|
2008-12-22 |
2015-01-21 |
Ono Pharmaceutical Co |
乙炔基吲哚化合物
|
|
WO2010147133A1
(ja)
|
2009-06-17 |
2010-12-23 |
小野薬品工業株式会社 |
新規なイミダゾピリジン化合物
|
|
WO2010151804A1
(en)
*
|
2009-06-26 |
2010-12-29 |
Map Pharmaceuticals, Inc. |
Administration of dihydroergotamine mesylate particles using a metered dose inhaler
|
|
CA2938650C
(en)
|
2009-09-04 |
2018-01-09 |
Raptor Pharmaceuticals Inc. |
Use of aerosolized levofloxacin for treating cystic fibrosis
|
|
WO2011066537A1
(en)
|
2009-11-30 |
2011-06-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide therapy for the treatment of von hippel - lindau disease (vhl) and renal clear cell carcinoma (rcc)
|
|
MY162757A
(en)
|
2010-06-21 |
2017-07-14 |
Ono Pharmaceutical Co |
New Crystalline Forms of 4,4’-[4-Fluoro-7-({4-[4-(3-Fluoro-2-Methylphenyl) Butoxy] Phenyl}Ethynyl)-2-Methyl-1H-Indole-1, 3-Diyl] Dibutanoic Acid
|
|
MY160914A
(en)
|
2010-12-02 |
2017-03-31 |
Ono Pharmaceutical Co |
Novel compound and medical use thereof
|
|
EP4059499A1
(en)
|
2011-01-31 |
2022-09-21 |
Avalyn Pharma Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
|
JP6107650B2
(ja)
|
2011-03-18 |
2017-04-05 |
小野薬品工業株式会社 |
テトラヒドロカルボリン誘導体
|
|
US9242977B2
(en)
|
2012-04-26 |
2016-01-26 |
Ono Pharmaceutical Co., Ltd. |
Trk-inhibiting compound
|
|
SG10201700808UA
(en)
|
2013-02-19 |
2017-02-27 |
Ono Pharmaceutical Co |
Trk-INHIBITING COMPOUND
|
|
CA3172586A1
(en)
|
2013-07-31 |
2015-02-05 |
Avalyn Pharma Inc. |
Aerosol imatininb compounds and uses thereof
|
|
JP7066321B2
(ja)
|
2014-01-10 |
2022-05-13 |
アヴァリン ファーマ インク． |
エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用
|
|
US10016439B2
(en)
|
2014-01-31 |
2018-07-10 |
Ono Pharmaceutical Co., Ltd. |
Fused imidazole compounds
|
|
US12383608B2
(en)
|
2016-11-30 |
2025-08-12 |
Sumitomo Pharma Co., Ltd. |
WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptides
|
|
US20210100886A1
(en)
|
2017-03-30 |
2021-04-08 |
Sumitomo Dainippon Pharma Co., Ltd. |
Wt1 cancer antigen peptides and peptide conjugates comprising the peptides
|
|
WO2019049891A1
(ja)
|
2017-09-06 |
2019-03-14 |
小野薬品工業株式会社 |
Ｔｒｋ阻害剤とキナーゼ阻害剤の併用による癌治療方法
|
|
AU2019277632A1
(en)
|
2018-05-31 |
2020-12-24 |
National Cancer Center Japan |
Biomarker for judging efficacy of immune checkpoint inhibitor
|
|
TW202446772A
(zh)
|
2018-10-11 |
2024-12-01 |
日商小野藥品工業股份有限公司 |
Ｓｔｉｎｇ促效化合物
|
|
BR112022002098A2
(pt)
|
2019-08-05 |
2022-04-12 |
Nat Cancer Ct |
Biomarcadores para determinar a eficácia de inibidores da via de sinalização imune
|
|
US20230014137A1
(en)
|
2019-11-29 |
2023-01-19 |
Ono Pharmaceutical Co., Ltd. |
Compound having lysophosphatidic acid receptor agonist activity and pharmaceutical use thereof
|
|
EP4100010A4
(en)
|
2020-02-07 |
2024-02-14 |
Case Western Reserve University |
Compositions and methods for attenuating opioid induced cardio and/or respiratory depression
|
|
EP4134134A4
(en)
|
2020-04-10 |
2023-12-27 |
ONO Pharmaceutical Co., Ltd. |
STING AGONIST COMPOUND
|
|
US20230183316A1
(en)
|
2020-05-12 |
2023-06-15 |
Sumitomo Pharma Co., Ltd. |
Pharmaceutical composition for treating cancer
|
|
WO2022240897A1
(en)
|
2021-05-10 |
2022-11-17 |
Sepelo Therapeutics, Llc |
Pharmaceutical composition comprising delafloxacin for administration into the lung
|
|
WO2022251679A1
(en)
|
2021-05-27 |
2022-12-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide radicals for use as antiviral treatment for coronavirus infection
|
|
WO2023028364A1
(en)
|
2021-08-27 |
2023-03-02 |
Sepelo Therapeutics, Llc |
Targeted compositions and uses therof
|